Synthesis process of 9-azido-9-deoxy-N-hydroxyacetylneuraminic acid

Through the reaction of mannose with aqueous acetonitrile solution and catalyzed by recombinant E. coli K12 aldolase, combined with the azide reaction under a nitrogen environment, the synthesis process of 9-azido-9-deoxy-N-acetyl neuraminine was successfully simplified by the reaction of mannose with aqueous acetonitrile and the catalyzed by recombinant E. coli K12 aldolase, combined with the azide reaction under a nitrogen environment, the synthesis process of 9-azido-9-deoxy-N-acetyl neuraminine was successfully simplified by the fact that 9-azido-9-deoxy-N-acetyl neuraminine was , solves the problem of complex and high cost in the prior art, and achieves efficient and low-cost production.

CN118979085AInactive Publication Date: 2024-11-19CHENGDU YIMINGTONG TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310527175.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-11
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

9-azido-9-deoxy-N-acetylneuramine synthesis process is complex and costly, making it difficult to achieve efficient and low-cost production.

Method used

Mannose is used as raw material, and a series of specific chemical reaction steps include reaction with acetonitrile aqueous solution to generate ManNGcAc, recombinant E. coli K12 aldolase catalyzes the formation of Neu5GcAc, followed by azide reaction under a nitrogen environment, and finally in methanol solution. 9-azido-9-deoxy-N-acetyl neuraminine is produced.

Benefits of technology

The synthesis process of 9-azido-9-deoxy-N-acetyl neuraminine is simplified, the production cost is reduced, the yield and product purity is improved, and an efficient synthesis process is achieved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004223133310000011
    Figure HDA0004223133310000011
Patent Text Reader

Abstract

The invention provides a synthesis process of 9-azido-9-deoxy-N-hydroxyacetylneuraminic acid, and relates to the technical field of synthesis of the 9-azido-9-deoxy-N-hydroxyacetylneuraminic acid. Based on a synthesis process of 9-azido-9-deoxy-N-hydroxyacetylneuraminic acid, the synthesis process comprises the following steps: S1, synthesizing ManNGcAc; s2, synthesizing Neu5GcAc, and synthesizing Neu5GcAc; s3, synthesis of 1 to Met-Neu5GcAc is carried out; s4, synthesizing 1-Met-9-Ts-Neu5GcAc, and carrying out reduced pressure distillation to obtain 1-Met-9 S5, synthesis of 9 to N3 to Neu5GcAc is carried out; and S6, synthesizing the 9AzNeu5Gc. The preparation method comprises the following steps: taking mannose as a raw material, reacting mannose with acetoxychloride to generate ManNGcAc, reacting mannose with sodium pyruvate in a KH2PO4 buffer solution to generate Neu5GcAc, reacting 5-acetoxyacetamide-3, 5-dideoxy-D-propyltrioxy-D-oligosaccharyl-2-nonyl ketonic acid with trifluoroacetic acid in a methanol solvent to generate 1-Met-Neu5GcAc, reacting 5-acetoxyacetamide-3, 5-dideoxy-D-propyltrioxy-D-oligosaccharyl-2-nonyl ketonic acid with pyridine as a solvent in a nitrogen environment to generate 1-Met-Neu5GcAc, and reacting 5-acetoxyacetamide-3, 5-dideoxy-D-propyltrioxy-D-nonyl ketonic acid The method comprises the following steps: reacting 1-Met-9-Ts-Neu5GcAc with paratoluensulfonyl chloride to generate 1-Met-9-Ts-Neu5GcAc, adding sodium azide to react in a nitrogen environment by taking a mixed solution of acetone and water as a solvent to generate 9-N3-Neu5GcAc, and reacting 9-N3-Neu5GcAc with sodium methoxide in a methanol solution to generate 9AzNeu5Gc.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of 9-azido-9-deoxy-N-glycolylneuraminic acid synthesis, in particular to a synthesis process of 9-azido-9-deoxy-N-glycolylneuraminic acid. Background Art

[0002] 9-Azido-9-deoxy-N-glycolylneuraminic acid is a 9-azido analog of Neu5Gc, which can be used for metabolic remodeling of cell surface sialoglycans. The 9-azido analog of Neu5Gc can be incorporated into the synthesis and metabolism in mammalian cells. The added sialic acid analog makes fluorescent imaging of cell surface sialoglycans and proteomic analysis of sialoglycoproteins possible. It is applied to metabolic engineering cell surfaces of sialoglycans terminated with different sialic acids or their 9-azido analogs. Recombinant cells expressing specific sialoglycoproteins have a significant affinity for the subtilisin cytotoxin (SubAB) secreted by Shiga toxin-producing Escherichia coli. The 9-azido analog of Neu5Gc provides a general tool for metabolic remodeling of cell surface properties and regulating pathogen-host interactions.

[0003] However, the current synthesis process of 9-azido-9-deoxy-N-glycolylneuraminic acid is complicated and the cost is high. Therefore, a synthesis process of 9-azido-9-deoxy-N-glycolylneuraminic acid is provided. Summary of the invention

[0004] 1. Technical issues to be solved

[0005] In view of the shortcomings of the prior art, the present invention provides a synthesis process of 9-azido-9-deoxy-N-glycolylneuraminic acid, which solves the problem of complex synthesis process of 9-azido-9-deoxy-N-glycolylneuraminic acid.

[0006] (II) Technical solution

[0007] To achieve the above object, the present invention is implemented by the following technical scheme: a synthesis process of 9-azido-9-deoxy-N-glycolylneuraminic acid, comprising the following steps:

[0008] S1. Synthetic compound N-acetoxyacetic acid-D-mannosamine (ManNGcAc)

[0009] A. Add mannose to a container, add HCl aqueous solution to dissolve it, and place it on a constant temperature magnetic stirrer and stir it overnight at 60°C. After the solution reacted overnight, dry the residue on a rotary evaporator to remove the solvent to obtain a compound;

[0010] B. Add a mixture of acetonitrile and water to the obtained compound to dissolve it, then cool the temperature to below 0°C in an ice bath and add NaHCO3;

[0011] C. Add acetoxy chloride to the reaction mixture, continue stirring at 0°C for 2 hours, then remove the ice bath, stir at room temperature for 2 hours, add methanol to the mixture to remove the solvent, and then purify it by silica gel column chromatography with ethyl acetate:methanol:water=8:1:0.2 to obtain the product ManNGcAc;

[0012] S2. Synthesis of the compound 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc)

[0013] A. Dissolve one part of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) and one part of sodium pyruvate in 80 mL of KH2PO4 buffer (50 mM) and then add recombinant Escherichia coli K12 aldolase;

[0014] B. The reaction was shaken continuously at 37°C for 2 days, and the product was purified by ion exchange chromatography with 1M formic acid aqueous solution, monitored by TLC, and the plate was climbed using a developing solvent of DCM:MeOH=1:1 polarity, Rf=0.1, and the product was preliminarily identified to obtain 3.45g Neu5GcAc;

[0015] S3. Synthetic compound 1-methyl-5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (1-Met-Neu5GcAc)

[0016] A. Add one portion of 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc) and one portion of MeOH solution to a three-necked flask to dissolve them. Add a rubber stopper with a thermometer and a constant pressure dropping funnel to the three-necked flask and place it on a constant temperature magnetic stirrer. Add one portion of trifluoroacetic acid to the constant pressure dropping funnel and drop it into the reaction system within 5 minutes. Stir the solution at room temperature overnight.

[0017] B. The methyl ester product was purified by silica gel column chromatography and monitored by TLC using a developing solvent of DCM:MeOH=4:1 polarity for climbing the plate, Rf=0.4, and the product was preliminarily identified to obtain 2.17 g of white powder product 1-Met-Neu5GcAc;

[0018] S4. Synthetic compound 1-methyl-5-acetoxyacetamide-9-toluenesulfonyl-3,5,9-trioxy-D-glyceryl-D-oligosaccharide-2-nonylketone acid (1-Met-9-Ts-Neu5GcAc)

[0019] A. Put one portion of 1-Met-Neu5GcAc into each 200mL three-necked flask, and then add one portion of dry pyridine to dissolve it. Install a rubber stopper and a tee with a thermometer into the three-necked flask, tie a balloon filled with nitrogen to the tee, replace it with nitrogen three times, put it on a magnetic stirrer, add ice cubes to the secondary support basin, and cool the reaction system to 0°C. After the reaction system cools to 0°C, pour in 0.86g of p-toluenesulfonyl chloride TsCl, continue stirring, remove the ice water bath, slowly raise the temperature of the reaction system to room temperature, and stir overnight;

[0020] B. The product was purified by silica gel column chromatography and monitored by TLC, using a developing solvent of DCM:MeOH=9:1 polarity to climb the plate, Rf=0.5, and the product was preliminarily identified to obtain an off-white foam with a yield of 50%;

[0021] S5. Synthesis of the compound 5-acetoxyacetamide-9-azido-3,5,9-trideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (9-N3-Neu5GcAc)

[0022] A. Add one portion of 1-Met-9-Ts-Neu5GcAc to a 100mL three-necked flask, then add 30mL of acetone and 10mL of H2O to dissolve it, then add one portion of sodium azide, add a spherical condenser and a tee to the three-necked flask, tie a balloon filled with nitrogen to the tee, replace it with nitrogen three times, put it on a constant temperature magnetic stirrer, adjust the temperature to 80°C, and heat the reaction system under reflux at this temperature for 2 days;

[0023] B. The crude product was purified by silica gel column chromatography and monitored by TLC. The developing solvent was DCM: MeOH = 1:1 polarity. Rf = 0.1. The product was preliminarily identified to obtain 0.35 g of light yellow powder with a yield of 59%;

[0024] S6. Synthesis of compound 9-azido-9-deoxy-N-hydroxyacetylneuraminic acid (9AzNeu5Gc)

[0025] A. Add a portion of 9-N3-Neu5GcAc obtained in S5 to a single-mouth bottle, then add MeOH solution to dissolve it, then add MeONa, and place the single-mouth bottle on a magnetic stirrer for 15 minutes. Then add H ion exchange resin (AmberliteIR 120), adjust the pH of the mixture to 7.0, and filter to obtain a yellow filtrate;

[0026] B. The filtrate was dried on a rotary evaporator to remove the solvent, and the product was purified by silica gel column chromatography and monitored by TLC using a developing solvent with a polarity of DCM:MeOH = 1:1. Rf = 0.05, and the product was preliminarily identified to obtain the target product with a yield of 78%.

[0027] Preferably, in step S1:

[0028] A. Mannose (1.0 g, 4.52 mmol) and HCl (2 mol, 40 ml) need to be put into each 0.5 L container, assuming that the resulting compound is 1 portion;

[0029] B. The mixing ratio of acetonitrile and water is 1:1, and 70 ml of acetonitrile and 70 ml of water are required for each compound;

[0030] C. Under ice-cooling conditions, NaHCO3 (3.80 g, 45.20 mmol) was added to each solution, and acetoxychloride (0.97 ml, 9.04 mmol) was added to each reaction mixture.

[0031] Preferably, in step S2:

[0032] A. One part of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) and one part of sodium pyruvate need to be added to every 80 mL of KH2PO4 buffer (50 mM);

[0033] B. one portion of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) (4.12 g, 14.7 mmol);

[0034] C. One portion of sodium pyruvate was (8.08 g, 73.5 mmol).

[0035] Preferably, in step S3:

[0036] A. 3.45 g (9.4 mmol, 1.0 eq) of 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc) per portion;

[0037] B. Each portion of MeOH solution is 100 mL;

[0038] C. Each portion of trifluoroacetic acid was 1.5 mL (20.2 mmol, 2.1 eq).

[0039] Preferably, in step S4:

[0040] A. 1.15 g (3.0 mmol, 1.0 eq) of 1-Met-Neu5GcAc per portion;

[0041] B. Each portion of 1-Met-Neu5GcAc needs to be added with 40 mL of dry pyridine;

[0042] C. Tosyl chloride TsCl (4.5 mmol, 1.5 eq).

[0043] Preferably, in step S5:

[0044] A. 0.81 g (1.5 mmol, 1.0 eq) of 1-Met-9-Ts-Neu5GcAc;

[0045] B. One portion of sodium azide was 0.98 g (15.1 mmol, 10.0 eq).

[0046] Preferably, in step S6:

[0047] A. 0.39 (1.0 mmol, 1.0 eq) of 9-N3-Neu5GcAc needs to be put into each 100 mL single-necked bottle;

[0048] B. The amount of MeONa solution added was 20 mL, and the amount of MeONa added was 0.11 g (2.0 mmol, 2.0 eq).

[0049] How it works: First pass.

[0050] (III) Beneficial effects

[0051] The present invention provides a synthesis process of 9-azido-9-deoxy-N-glycolylneuraminic acid, which has the following beneficial effects:

[0052] The method uses mannose as a raw material, adds an acetonitrile aqueous solution under acidic conditions, and reacts with acetoxy chloride to generate ManNGcAc; reacts with sodium pyruvate in a KH2PO4 buffer under the catalysis of recombinant Escherichia coli K12 aldolase to generate Neu5GcAc; reacts 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid with trifluoroacetic acid in a methanol solvent to generate 1-Met-Neu5GcAc; reacts with p-toluenesulfonyl chloride in a nitrogen environment using pyridine as a solvent to generate 1-Met-9-Ts-Neu5GcAc; and reacts with sodium azide in a nitrogen environment using a mixed solution of acetone and water as a solvent to generate 9-N3-Neu5GcAc; and reacts with sodium methoxide in a methanol solution to generate 9AzNeu5Gc. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] Figure 1 The present invention provides a synthetic route for 9-azido-9-deoxy-N-glycolylneuraminic acid.

[0054] The invention generates mannosamine hydrochloride by reacting mannose with hydrochloric acid, then adds acetoxyacetyl chloride, introduces the protection form of hydroxyl group by using acetoxyacetyl chloride, obtains N-acetyl-hydroxymannosamine, adds sodium bicarbonate to remove excess hydrochloric acid, the reaction of sodium bicarbonate with hydrochloric acid is an endothermic process, reacts in an ice water bath to help the reaction system to maintain the same temperature, adds methanol to help remove other solvents remaining after the reaction, uses a solution system of ethyl acetate: methanol: water = 8: 1: 0.2 to purify the obtained crude product by silica gel column, removes other impurities, spots the plate to confirm the product, collects the product, spins the product to dryness by using a rotary evaporator, and catalyzes pyruvate by Escherichia coli K12 aldolase The salt was condensed, and the pH value of the solution was kept relatively stable by KH2PO4 buffer. The plate was climbed by ion exchange chromatography using a developing solvent of DCM: MeOH = 1:1 polarity. The product was preliminarily confirmed by spotting the plate. The product was spin-dried by a rotary evaporator. 5-acetoxyacetamide-3 and 5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketose acid were esterified with methanol. Trifluoroacetic acid is an excellent solvent for organic reactions and can obtain results that are difficult to obtain in general solvents. It has strong acidity and can catalyze many acid-catalyzed chemical reactions. It can be removed by distillation after post-treatment. Slowly dripping trifluoroacetic acid into the reaction system can make the reaction more complete. Silica gel column chromatography can be used to separate The crude product is obtained by removing impurities, and 1-methyl-5-acetoxyacetamide-3 and 5-dideoxy-D-glycerol-2-nonyl ketone acid are fully reacted with pyridine to form oxygen anions, and then TsCl is added. The HCl generated by TsCl combines to promote the reaction. The pyridine used must be dry. Too much water in the system will affect the reaction. The obtained crude product is purified by silica gel column, and the developing solvent is DCM: MeOH = 9:1 polarity to climb the plate, spot the plate to confirm the obtained crude product, and then spin dry, and sodium azide is reacted with 1-methyl-5-acetoxyacetamide-9-toluenesulfonyl-3,5,9-trioxy-D-glycerol- D-oligosaccharide-2-nonyl ketone acid reacts to generate azide compounds. The nucleophilic substitution reaction between the azide compounds and the ester group can introduce the azide group into the target compound. Sodium azide is a highly toxic drug. Be sure to take good protection during the operation and complete the operation in a fume hood. After the reaction is complete, it is purified by silica gel column to obtain a crude product. In the process of synthesizing 9-azido-9-deoxy-N-hydroxyacetylneuraminic acid, sodium methoxide is an alkaline catalyst. The CH3O-oxygen of sodium methoxide attacks the carbon atom of the ester bond, causing the original CO electron cloud of the ester bond to move toward the oxygen until the bond is broken and the original -OCH3 group is removed. H ion exchange resin is added to make the pH value of the reaction solution 7.0. The product is purified by silica gel column chromatography. DETAILED DESCRIPTION

[0055] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0056] Example:

[0057] like Figure 1 As shown, the embodiment of the present invention provides a synthesis process based on 9-azido-9-deoxy-N-glycolylneuraminic acid, comprising the following steps:

[0058] S1. Synthetic compound N-acetoxyacetic acid-D-mannosamine (ManNGcAc)

[0059] A. Add mannose to a container, add HCl aqueous solution to dissolve it, and place it on a constant temperature magnetic stirrer and stir it overnight at 60°C. After the solution reacted overnight, dry the residue on a rotary evaporator to remove the solvent to obtain a compound;

[0060] B. Add a mixture of acetonitrile and water to the obtained compound to dissolve it, then cool the temperature to below 0°C in an ice bath and add NaHCO3;

[0061] C. Add acetoxy chloride to the reaction mixture, continue stirring at 0°C for 2 hours, then remove the ice bath, stir at room temperature for 2 hours, add methanol to the mixture to remove the solvent, and then purify it by silica gel column chromatography with ethyl acetate:methanol:water=8:1:0.2 to obtain the product ManNGcAc;

[0062] S2. Synthesis of the compound 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc)

[0063] A. Dissolve one part of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) and one part of sodium pyruvate in 80 mL of KH2PO4 buffer (50 mM) and then add recombinant Escherichia coli K12 aldolase;

[0064] B. The reaction was shaken continuously at 37°C for 2 days, and the product was purified by ion exchange chromatography with 1M formic acid aqueous solution, monitored by TLC, and the plate was climbed using a developing solvent of DCM:MeOH=1:1 polarity, Rf=0.1, and the product was preliminarily identified to obtain 3.45g Neu5GcAc;

[0065] S3. Synthetic compound 1-methyl-5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (1-Met-Neu5GcAc)

[0066] A. Add one portion of 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc) and one portion of MeOH solution to a three-necked flask to dissolve them. Add a rubber stopper with a thermometer and a constant pressure dropping funnel to the three-necked flask and place it on a constant temperature magnetic stirrer. Add one portion of trifluoroacetic acid to the constant pressure dropping funnel and drop it into the reaction system within 5 minutes. Stir the solution at room temperature overnight.

[0067] B. The methyl ester product was purified by silica gel column chromatography and monitored by TLC using a developing solvent of DCM:MeOH=4:1 polarity for climbing the plate, Rf=0.4, and the product was preliminarily identified to obtain 2.17 g of white powder product 1-Met-Neu5GcAc;

[0068] S4. Synthetic compound 1-methyl-5-acetoxyacetamide-9-toluenesulfonyl-3,5,9-trioxy-D-glyceryl-D-oligosaccharide-2-nonylketone acid (1-Met-9-Ts-Neu5GcAc)

[0069] A. Put one portion of 1-Met-Neu5GcAc into each 200mL three-necked flask, and then add one portion of dry pyridine to dissolve it. Install a rubber stopper and a tee with a thermometer into the three-necked flask, tie a balloon filled with nitrogen to the tee, replace it with nitrogen three times, put it on a magnetic stirrer, add ice cubes to the secondary support basin, and cool the reaction system to 0°C. After the reaction system cools to 0°C, pour in 0.86g of p-toluenesulfonyl chloride TsCl, continue stirring, remove the ice water bath, slowly raise the temperature of the reaction system to room temperature, and stir overnight;

[0070] B. The product was purified by silica gel column chromatography and monitored by TLC, using a developing solvent of DCM:MeOH=9:1 polarity to climb the plate, Rf=0.5, and the product was preliminarily identified to obtain an off-white foam with a yield of 50%;

[0071] S5. Synthesis of the compound 5-acetoxyacetamide-9-azido-3,5,9-trideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (9-N3-Neu5GcAc)

[0072] A. Add one portion of 1-Met-9-Ts-Neu5GcAc to a 100mL three-necked flask, then add 30mL of acetone and 10mL of H2O to dissolve it, then add one portion of sodium azide, add a spherical condenser and a tee to the three-necked flask, tie a balloon filled with nitrogen to the tee, replace it with nitrogen three times, put it on a constant temperature magnetic stirrer, adjust the temperature to 80°C, and heat the reaction system under reflux at this temperature for 2 days;

[0073] B. The crude product was purified by silica gel column chromatography and monitored by TLC using a developing solvent of DCM:MeOH=1:1 polarity for climbing the plate, Rf=0.1, and the product was preliminarily identified to obtain 0.35 g of light yellow powder with a yield of 59%;

[0074] S6. Synthesis of compound 9-azido-9-deoxy-N-hydroxyacetylneuraminic acid (9AzNeu5Gc)

[0075] A. Add a portion of 9-N3-Neu5GcAc obtained in S5 to a single-mouth bottle, then add MeOH solution to dissolve it, then add MeONa, and place the single-mouth bottle on a magnetic stirrer for 15 minutes. Then add H ion exchange resin (AmberliteIR 120), adjust the pH of the mixture to 7.0, and filter to obtain a yellow filtrate;

[0076] B. The filtrate was dried on a rotary evaporator to remove the solvent, and the product was purified by silica gel column chromatography and monitored by TLC using a developing solvent with a polarity of DCM:MeOH = 1:1. Rf = 0.05, and the product was preliminarily identified to obtain the target product with a yield of 78%.

[0077] In step S1:

[0078] A. Mannose (1.0 g, 4.52 mmol) and HCl (2 mol, 40 ml) need to be put into each 0.5 L container, assuming that the resulting compound is 1 part;

[0079] B. The mixing ratio of acetonitrile and water is 1:1, and 70 ml of acetonitrile and 70 ml of water are required for each compound;

[0080] C. Under ice-cooling conditions, NaHCO3 (3.80 g, 45.20 mmol) was added to each solution, and acetoxychloride (0.97 ml, 9.04 mmol) was added to each reaction mixture.

[0081] In step S2:

[0082] A. One part of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) and one part of sodium pyruvate need to be added to every 80 mL of KH2PO4 buffer (50 mM);

[0083] B. one portion of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) (4.12 g, 14.7 mmol);

[0084] C. One portion of sodium pyruvate was (8.08 g, 73.5 mmol).

[0085] In step S3:

[0086] A. 3.45 g (9.4 mmol, 1.0 eq) of 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc) per portion;

[0087] B. Each portion of MeOH solution is 100 mL;

[0088] C. Each portion of trifluoroacetic acid was 1.5 mL (20.2 mmol, 2.1 eq).

[0089] In step S4:

[0090] A. 1.15 g (3.0 mmol, 1.0 eq) of 1-Met-Neu5GcAc per portion;

[0091] B. Each portion of 1-Met-Neu5GcAc needs to be added with 40 mL of dry pyridine;

[0092] C. Tosyl chloride TsCl (4.5 mmol, 1.5 eq).

[0093] In step S5:

[0094] A. 0.81 g (1.5 mmol, 1.0 eq) of 1-Met-9-Ts-Neu5GcAc;

[0095] B. One portion of sodium azide was 0.98 g (15.1 mmol, 10.0 eq).

[0096] In step S6:

[0097] A. 0.39 (1.0 mmol, 1.0 eq) of 9-N3-Neu5GcAc needs to be put into each 100 mL single-necked bottle;

[0098] B. The amount of MeONa solution added was 20 mL, and the amount of MeONa added was 0.11 g (2.0 mmol, 2.0 eq).

[0099] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A process for synthesizing 9-azido-9-deoxy-N-glycolylneuraminic acid, Features: The following steps are involved: S1. Synthetic compound N-acetoxyacetic acid-D-mannosamine (ManNGcAc) A. Add mannose to a container, add HCl aqueous solution to dissolve it, and place it on a constant temperature magnetic stirrer and stir it overnight at 60°C. After the solution reacted overnight, dry the residue on a rotary evaporator to remove the solvent to obtain a compound; B. Mix acetonitrile and water and add them to the obtained compound to dissolve it. Then cool it to 0°C in an ice bath and add NaHCO 3 ; C. Add acetoxy chloride to the reaction mixture, continue stirring at 0°C for 2 hours, then remove the ice bath, stir at room temperature for 2 hours, add methanol to the mixture to remove the solvent, and then purify it by silica gel column chromatography with ethyl acetate:methanol:water=8:1:0.2 to obtain the product ManNGcAc; S2. Synthesis of the compound 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc) A. Dissolve one part of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) and one part of sodium pyruvate in 80 mL of KH2PO4 buffer (50 mM) and then add recombinant Escherichia coli K12 aldolase; B. The reaction was shaken continuously at 37°C for 2 days, and the product was purified by ion exchange chromatography with 1M formic acid aqueous solution, monitored by TLC, and the plate was climbed using a developing solvent of DCM:MeOH=1:1 polarity, Rf=0.1, and the product was preliminarily identified to obtain 3.45g Neu5GcAc; S3. Synthetic compound 1-methyl-5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (1-Met-Neu5GcAc) A. Add one portion of 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc) and one portion of MeOH solution to a three-necked flask to dissolve them. Add a rubber stopper with a thermometer and a constant pressure dropping funnel to the three-necked flask and place it on a constant temperature magnetic stirrer. Add one portion of trifluoroacetic acid to the constant pressure dropping funnel and drop it into the reaction system within 5 minutes. Stir the solution at room temperature overnight. B. The methyl ester product was purified by silica gel column chromatography and monitored by TLC using a developing solvent of DCM:MeOH=4:1 polarity for climbing the plate, Rf=0.4, and the product was preliminarily identified to obtain 2.17 g of white powder product 1-Met-Neu5GcAc; S4. Synthetic compound 1-methyl-5-acetoxyacetamide-9-toluenesulfonyl-3,5,9-trioxy-D-glyceryl-D-oligosaccharide-2-nonylketone acid (1-Met-9-Ts-Neu5GcAc) A. Put one portion of 1-Met-Neu5GcAc into each 200mL three-necked flask, and then add one portion of dry pyridine to dissolve it. Install a rubber stopper and a tee with a thermometer into the three-necked flask, tie a balloon filled with nitrogen to the tee, replace it with nitrogen three times, put it on a magnetic stirrer, add ice cubes to the secondary support basin, and cool the reaction system to 0°C. After the reaction system cools to 0°C, pour in 0.86g of p-toluenesulfonyl chloride TsCl, continue stirring, remove the ice water bath, slowly raise the temperature of the reaction system to room temperature, and stir overnight; B. The product was purified by silica gel column chromatography and monitored by TLC, using a developing solvent of DCM:MeOH=9:1 polarity to climb the plate, Rf=0.5, and the product was preliminarily identified to obtain an off-white foam with a yield of 50%; S5. Synthesis of the compound 5-acetoxyacetamide-9-azido-3,5,9-trideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (9-N3-Neu5GcAc) A. Add one portion of 1-Met-9-Ts-Neu5GcAc to a 100 mL three-necked flask, then add 30 mL of acetone and 10 mL of H 2 O to dissolve it, then add a portion of sodium azide, add a spherical condenser and a tee to the three-necked flask, tie a balloon filled with nitrogen to the tee, replace it with nitrogen three times, put it on a constant temperature magnetic stirrer, adjust the temperature to 80°C, and heat the reaction system under reflux at this temperature for 2 days; B. The crude product was purified by silica gel column chromatography and monitored by TLC. The developing solvent was DCM: MeOH = 1:1 polarity. Rf = 0.

1. The product was preliminarily identified to obtain 0.35 g of light yellow powder with a yield of 59%; S6. Synthesis of compound 9-azido-9-deoxy-N-hydroxyacetylneuraminic acid (9AzNeu5Gc) A. Add a portion of 9-N3-Neu5GcAc obtained in S5 to a single-mouth bottle, then add MeOH solution to dissolve it, then add MeONa, and place the single-mouth bottle on a magnetic stirrer for 15 minutes. Then add H ion exchange resin (AmberliteIR120), adjust the pH of the mixture to 7.0, and filter to obtain a yellow filtrate; B. The filtrate was dried on a rotary evaporator to remove the solvent, and the product was purified by silica gel column chromatography and monitored by TLC using a developing solvent with a polarity of DCM:MeOH = 1:

1. Rf = 0.05, and the product was preliminarily identified to obtain the target product with a yield of 78%.

2. A process for synthesizing 9-azido-9-deoxy-N-glycolylneuraminic acid according to claim 1, Features: In step S1: A. Mannose (1.0 g, 4.52 mmol) and HCl (2 mol, 40 ml) need to be put into each 0.5 L container, assuming that the resulting compound is 1 portion; B. The mixing ratio of acetonitrile and water is 1:1, and 70 ml of acetonitrile and 70 ml of water are required for each compound; C. Under ice bath conditions, each solution needs to add NaHCO 3 (3.80 g, 45.20 mmol), acetoxy chloride (0.97 ml, 9.04 mmol) was added to each reaction mixture.

3. A process for synthesizing 9-azido-9-deoxy-N-glycolylneuraminic acid according to claim 1, Features: In step S2: A. One part of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) and one part of sodium pyruvate need to be added to every 80 mL of KH2PO4 buffer (50 mM); B. one portion of N-acetoxyacetic acid-D-mannosamine (ManNGcAc) (4.12 g, 14.7 mmol); C. One portion of sodium pyruvate was (8.08 g, 73.5 mmol).

4. A process for synthesizing 9-azido-9-deoxy-N-glycolylneuraminic acid according to claim 1, Features: In step S3: A. 3.45 g (9.4 mmol, 1.0 eq) of 5-acetoxyacetamide-3,5-dideoxy-D-glycerotrioxy-D-oligosaccharide-2-nonylketone acid (Neu5GcAc) per portion; B. Each portion of MeOH solution is 100 mL; C. Each portion of trifluoroacetic acid was 1.5 mL (20.2 mmol, 2.1 eq).

5. A process for synthesizing 9-azido-9-deoxy-N-glycolylneuraminic acid according to claim 1, Features: In step S4: A. 1.15 g (3.0 mmol, 1.0 eq) of 1-Met-Neu5GcAc per portion; B. Each portion of 1-Met-Neu5GcAc needs to be added with 40 mL of dry pyridine; C. Tosyl chloride TsCl (4.5 mmol, 1.5 eq).

6. A process for synthesizing 9-azido-9-deoxy-N-glycolylneuraminic acid according to claim 1, Features: In step S5: A. 0.81 g (1.5 mmol, 1.0 eq) of 1-Met-9-Ts-Neu5GcAc; B. One portion of sodium azide was 0.98 g (15.1 mmol, 10.0 eq).

7. A process for synthesizing 9-azido-9-deoxy-N-glycolylneuraminic acid according to claim 1, Features: In step S6: A. 0.39 (1.0 mmol, 1.0 eq) of 9-N3-Neu5GcAc needs to be put into each 100 mL single-necked bottle; B. The amount of MeONa solution added was 20 mL, and the amount of MeONa added was 0.11 g (2.0 mmol, 2.0 eq).